Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis

References

• Tannoury JN, Abboud BN. Idiopathic sclerosing encapsulating peritonitis: abdominal cocoon. World J Gastroenterol. 2012;18:1999–2004.
   PubMed Web of Science ®Google Scholar
• Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol. 2015;21:675–687.
   PubMed Web of Science ®Google Scholar
• Chin A, Yeun J. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis. 2006;47:697–712.
   PubMed Web of Science ®Google Scholar
• Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729–737.
   PubMed Web of Science ®Google Scholar
• Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25:S19–S29.
   PubMed Web of Science ®Google Scholar
• Brown MC, Simpson K, Kerssens JJ, et al.; The Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol. 2009;4:1222–1229.
   PubMed Web of Science ®Google Scholar
• Wong YY, Wong PN, Mak SK, et al. Persistent sterile peritoneal inflammation after catheter removal for refractory bacteria peritonitis predicts full-blown encapsulatingperitoneal sclerosis. Perit Dial Int. 2013;33:507–514.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Kwan BC, Chow KM, et al. Persistent symptomatic intra-abdominal collection after catheter removal for PD-related peritonitis. Perit Dial Int. 2011;31:34–38.
   PubMed Web of Science ®Google Scholar
• Nakamoto H. Encapsulating peritoneal sclerosis: a clinician’s approach to diagnosis and medical treatment. Perit Dial Int. 2005;25:30–38.
   PubMed Web of Science ®Google Scholar
• Kawanishi H, Harada Y, Sakikubo E, et al. Surgical treatment for sclerosing encapsulating peritonitis. Adv Perit Dial. 2000;16:252–256.
   PubMedGoogle Scholar
• Celicout B, Levard H, Hay J, et al. Sclerosing encapsulating peritonitis: early and late results of surgical management in 32 cases. French Associations for Surgical Research. Dig Surg. 1998;15:697–702.
   PubMed Web of Science ®Google Scholar
• Pusateri R, Ross R, Marshall R, et al. Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature. Am J Kidney Dis. 1986;8:56–60.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Kawanishi H, Mujais S, et al. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20:S43–S55.
   PubMedGoogle Scholar
• Kasai K, Terawaki H, Otsuka Y, et al. [Clinical evaluation of cases with massive ascites accumulation after discontinuation of CAPD: an attempt to establish the concept of the pre-sclerosing encapsulating peritonitis(pre-SEP) state]. Nihon Jinzo Gakkai Shi. 2000;42:346–352.
   PubMedGoogle Scholar
• Sawada T, Ishii Y, Tojimbara T, et al. The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol Res. 2002;46:505–510.
   PubMed Web of Science ®Google Scholar
• Kyuden I, Ito T, Masaki T, et al. TGF-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells. Perit Dial Int. 2005;25:483–491.
   PubMed Web of Science ®Google Scholar
• Slingeneyer A. Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis. Contrib Nephrol. 1987;57:239–247.
   PubMedGoogle Scholar
• Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30:393–423.
   PubMed Web of Science ®Google Scholar
• Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138–147.
   Web of Science ®Google Scholar
• Tarzi RM, Lim A, Moser S, et al. Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol. 2008;3:1702–1710.
   PubMed Web of Science ®Google Scholar
• Stafford-Johnson DB, Wilson TE, Francis IR, et al. CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis. J Comput Assist Tomogr. 1998;22:295–299.
   PubMed Web of Science ®Google Scholar
• Hirahara I, Inoue M, Okuda K, et al. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis: a multi centre study in Japan. Nephrol Dial Transplant. 2006;22:560–567.
   PubMed Web of Science ®Google Scholar
• Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998;13:154–159.
   PubMed Web of Science ®Google Scholar
• Tseng CC, Chen JB, Wang IK, et al. Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS. PLoS One. 2018;13:e0190079.
   PubMed Web of Science ®Google Scholar
• Bilgic A, Sezer S, Ozdemir FN, et al. Clinical outcome after transfer from peritoneal dialysis to hemodialysis. Adv Perit Dial. 2006;22:94–98.
   PubMedGoogle Scholar
• Brimble KS, Walker M, Margetts PJ, et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol. 2006;17:2591–2598.
   PubMed Web of Science ®Google Scholar
• Soliman K, Herberth J, Fülöp T, et al. Refractory ascites as a presenting feature of extramedullary plasmacytoma in an end-stage renal disease patient with HIV infection. Clin Nephrol Case Stud. 2019;7:7–10.
   PubMedGoogle Scholar
• Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int. 2005;25:S83–S95.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Yamamoto H, Ikeda M, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis-Jikei experience 2002. Adv Perit Dial. 2002;18:144–148.
   PubMedGoogle Scholar